South Dakota · 2026 Regular Session · Bill
HB 1169: classify medetomidine as a Schedule III controlled substance and establish permissible uses.
Enacted Last action March 9, 2026: Signed by the Governor on 2026-03-09 H.J. 534
Plain-language summary
HB 1169 is a bill introduced in the South Dakota House on January 28, 2026. According to its official title, it concerns: classify medetomidine as a Schedule III controlled substance and establish permissible uses. Primary sponsor: Josephine Garcia (Republican), Bobbi Andera (Republican), Tamara Grove (Republican), Jana Hunt (Republican), Travis Ismay (Republican), Phil Jensen (Republican), Dylan Jordan (Republican), Al Novstrup (Republican), Kathy Rice (Republican), Brandei Schaefbauer (Republican). Most recent recorded action (March 9, 2026): Signed by the Governor on 2026-03-09 H.J. 534.
Sponsors
Primary sponsors: Josephine Garcia (Republican); Bobbi Andera (Republican); Tamara Grove (Republican); Jana Hunt (Republican); and 6 more.